Related Experiment Videos
Scintigraphy with 99mTc-pertechnetate in the evaluation of functional thyroidal autonomy
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)
|November 24, 1999
Summary
Thyroidal autonomy diagnosis relies on scintigraphy, not sonography. Measuring 99mTc-pertechnetate uptake under suppression (TCTUs) accurately quantifies autonomous thyroid tissue for risk stratification and therapy planning.
Area of Science:
- Nuclear Medicine
- Endocrinology
- Molecular Biology
Background:
- Iodine deficiency disorders persist in Europe.
- Sonography lacks specificity and sensitivity for evaluating autonomous thyroid tissue.
- Thyroidal autonomy is a functional state requiring functional imaging.
Purpose of the Study:
- To highlight the importance of scintigraphy for diagnosing thyroidal autonomy.
- To explain the molecular basis of iodine and pertechnetate uptake via the Na+/I- symporter (NIS).
- To establish a reliable scintigraphic method for quantifying thyroidal autonomy.
Main Methods:
- Utilizing 99mTc-pertechnetate (99mTcO4-) scintigraphy for sensitive and specific diagnosis.
- Characterizing the Na+/I- symporter (NIS) and its role in iodine/pertechnetate uptake.
- Performing quantitative and qualitative thyroid scintigraphy with gamma cameras and computer systems.
- Measuring global 99mTc-pertechnetate thyroid uptake (TCTU) and global 99mTc-pertechnetate thyroid uptake under suppression (TCTUs).
Main Results:
- Overexpression of NIS in hot nodules explains enhanced iodine clearance.
- A strong linear correlation exists between TCTU and 123I clearance.
- TCTUs provides a sensitive method for diagnosis and quantification of thyroidal autonomy.
Conclusions:
- Scintigraphy with 99mTc-pertechnetate is crucial for diagnosing thyroidal autonomy.
- The Na+/I- symporter (NIS) provides a molecular explanation for autonomous thyroid function.
- TCTUs is a valuable tool for risk stratification, radioiodine therapy planning, and evaluating treatment success.